Study design
The present randomized, double-blind, multicenter (two investigational sites) study was conducted from January 2020 to March 2021. After patient screening and a wash-out period of two weeks, 60 patients with symptomatic knee OA were randomly allocated to each group (PN or HMWHA) using the block randomization method (Microsoft Excel